81
1
Growth Score 81 in past quarter
-4 pts
Heat Score 1 in past quarter
-18 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
4003071
Enabling therapeutic application of Chimeric Antigen Receptor (CAR) T cells in solid tumors.
Yeda Research and Development Co. Ltd
About the Company
CTG Pharma has developed an innovative solution that will allow CAR T therapy for HER 2 positive solid tumors while mitigating toxicity and on-target off-tumor reactions. CTG Pharma has the best possible solutions, with a Library of 65K promoters, Safer CAR T for the treatment of solid tumors, applicable to any CAR, and Suitable for a variety of
tumor micro-environment conditions